STE monthly performance report
Monthly STE research: returns, drawdown, relative strength, seasonality, and key stats.
STE monthly report
—
Key takeaways
- Steris (STE) closed August 2026 at $232.71, up 1.89% for the month and +3.95% over the trailing 12 months.
- Year-to-date, STE is −8.21%, underperforming the S&P 500 which has returned +12.89% YTD.
- The stock is trading −0.92% versus its 200-day moving average ($234.88), a cautious technical signal.
- Over the past three years, STE has underperformed the S&P 500 by −69.32%, with a relative strength index reading of 60.2.
- Win rate over the trailing 39 months stands at 51.3% — 20 positive months versus 19 negative months.
Steris ended August 2026 at $232.71, posting a monthly return of +1.89%. The S&P 500 returned +3.05% over the same window, leaving relative performance at −1.16%.
The current quarter stands at +8.87% (Q3 2026 (QTD)), while medium-term trend remains soft: price is −0.92% versus the 200-day moving average ($234.88).
Year-to-date, STE is −8.21% against SPY +12.89%, a gap of −21.09%. The stock is currently −13.63% below its 52-week high, with maximum 3-year drawdown at −25.78%.
| Period | STE | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −0.06% | −0.20% | +0.14% |
| 1 Week | +1.03% | +3.90% | −2.88% |
| 1 Month | +1.89% | +3.05% | −1.16% |
| 3 Months | +7.30% | +7.11% | +0.18% |
| 6 Months |